| Company Name: | First Consulting Group Inc | | Ticker Symbol: | FCGI | | | WWW Address: | www.fcg.com | | CEO: | Larry R. Ferguson | | No. of Employees: | 2,716 | | Common Issue Type: | CS | | Business Description: | The Company provides information technology services and software products, primarily for health delivery, health plan and life sciences organizations.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Management Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | |  | - | - | 0 | 12.99 | 12.97 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 352.7 | 27.1 | 0.53 | 0.80 | 0.00 | 11.0 | 0.0 | 13.75 - 8.24 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 12.99 | $ | | PE Ratio - LTM | 11.0 | |
| Market Capitalisation | 352.7 | mil |
| Latest Shares Outstanding | 27.1 | mil |
| Earnings pS (EPS) | 0.80 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 102,298 | $ |
| Effective Tax Rate | 7.5 | % |
| Float | 26.0 | mil |
| Float as % of Shares Outstanding | 95.9 | % |
| Foreign Sales | 29 | mil |
| Domestic Sales | 235 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 19.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 28.3 | % |
| EBITDA Margin | 8.6 | % |
| Pre-Tax Profit Margin | 7.4 | % |
| Assets Turnover | 1.7 | % |
| Return on Assets (ROA) | 16.4 | % |
| Return on Equity (ROE) | 22.6 | % |
| Return on Capital Invested (ROCI) | 22.6 | % |
| Current Ratio | 3.0 | |
| Leverage Ratio (Assets/Equity) | 1.4 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 3.38 | $ |
| Cash pS | 3.17 | $ |
| Book-Value pS | 5.31 | $ |
| Tangible Book-Value pS | 4.63 | $ |
| Cash Flow pS | 1.45 | $ |
| Free Cash Flow pS | 0.76 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.45 | |
| Price/Tangible Book Ratio | 2.81 | |
| Price/Cash Flow | 9.0 | |
| Price/Free Cash Flow | 17.1 | |
| P/E as % of Industry Group | 41.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.0 | 102 | 4,368 | 14,287 |
| 4 Weeks | 12.99 | 12.74 | 12.89 | 0.8 | 106 | 3,342 | 60,147 |
| 13 Weeks | 12.99 | 9.37 | 10.15 | 28.0 | 143 | 4,228 | 262,132 |
| 26 Weeks | 12.99 | 8.24 | 9.01 | 44.2 | 160 | 3,080 | 388,139 |
| 52 Weeks | 13.75 | 8.24 | 13.49 | -3.7 | 98 | 2,654 | 666,137 |
| YTD | 12.99 | 12.74 | - | 0.5 | 105 | 5,167 | 41,335 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 12.97 | 12.93 | 12.84 | 10.56 | 10.23 | 0.53 | 0.71 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -0.10 | 0.5 | -0.81 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 8.59 | NA | -26.72 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 1.3 | 3.0 | -5.2 |
| Earnings % | 73.8 | 238.0 | 0.0 |
| EPS % | 61.3 | 226.1 | 0.0 |
| EPS $ | 0.38 | 0.52 | 1.56 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 46.42 |
| Current Ratio | 3.3 |
| Quick Ratio (Acid Test) | 3.2 |
| Liquidity Ratio (Cash) | 2.12 |
| Receivables Turnover | 8.4 |
| Average Collection Period | 43 |
| Working Capital/Equity | 63.2 |
| Working Capital pS | 2.68 |
| Cash-Flow pS | 1.10 |
| Free Cash-Flow pS | 0.67 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 8.31 |
| Financial Leverage Ratio (Assets/Equity) | 1.4 |
| Debt Ratio | 26.5 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 9.2 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.10 |
| Tobin's Q Ratio | 2.33 |
| Current P/E Ratio - LTM | 11.00 |
| Enterprise Value (EV)/EBITDA | 11.91 |
| Enterprise Value (EV)/Free Cash Flow | 32.23 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 2.81 |
| Price/Book Ratio - LTM | 2.45 |
| Price/Cash Flow Ratio | 9.0 |
| Price/Free Cash Flow Ratio - LTM | 17.1 |
| Price/Sales Ratio | 1.25 |
| P/E Ratio (1 month ago) - LTM | 10.9 |
| P/E Ratio (26 weeks ago) - LTM | 12.2 |
| P/E Ratio (52 weeks ago) - LTM | 67.5 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 41.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 16.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 1.14 |
| Tangible Book Value pS - LTM | 4.63 |
| Book Value pS - LTM | 5.31 |
| Capital Invested pS | 4.10 |
| Cash pS - LTM | 3.17 |
| Cash Flow pS - LTM | 1.45 |
| Free Cash Flow pS - LTM | 0.76 |
| Earnings pS (EPS) | 0.80 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 6.33 |
| Free Cash Flow Margin 5YEAR AVG | 0.70 |
| Net Profit Margin | 7.5 |
| Net Profit Margin - 5YEAR AVRG. | -0.4 |
| Equity Productivity | 2.50 |
| Return on Equity (ROE) | 18.7 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 2.50 |
| Return on Capital Invested (ROCI) | 18.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -1.3 |
| Assets Productivity | 2.00 |
| Return on Assets (ROA) | 13.8 |
| Return on Assets (ROA) - 5YEAR AVRG. | -0.9 |
| Gross Profit Margin | 28.3 |
| Gross Profit Margin - 5YEAR AVRG. | 32.1 |
| EBITDA Margin - LTM | 8.6 |
| EBIT Margin - LTM | 7.4 |
| Pre-Tax Profit Margin | 8.1 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.8 |
| Effective Tax Rate | 7.5 |
| Effective Tax Rate - 5YEAR AVRG. | -22.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 43 |
| Revenue per Employee | 102,298 |
| Net Income per Employee | 7,680 |
| Average Collection Period | 43 |
| Receivables Turnover | 8.4 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 0.86 |
| Assets/Revenue | 0.50 |
| Net Working Capital Turnover | 3.95 |
| Fixed Assets Turnover | 5.43 |
| Total Assets Turnover | 2.0 |
| Revenue per $ Cash | 4.75 |
| Revenue per $ Plant | 25.03 |
| Revenue per $ Common Equity | 2.50 |
| Revenue per $ Capital Invested | 2.50 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 19.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 27.7 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |